Cargando…
A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies
OBJECTIVES: To identify clinical factors associated with cancer risk in the idiopathic inflammatory myopathies (IIMs) and to systematically review the existing evidence related to cancer screening. METHODS: A systematic literature search was carried out on Medline, Embase and Scopus. Cancer risk wit...
Autores principales: | Oldroyd, Alexander G S, Allard, Andrew B, Callen, Jeffrey P, Chinoy, Hector, Chung, Lorinda, Fiorentino, David, George, Michael D, Gordon, Patrick, Kolstad, Kate, Kurtzman, Drew J B, Machado, Pedro M, McHugh, Neil J, Postolova, Anna, Selva-O’Callaghan, Albert, Schmidt, Jens, Tansley, Sarah, Vleugels, Ruth Ann, Werth, Victoria P, Aggarwal, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213426/ https://www.ncbi.nlm.nih.gov/pubmed/33599244 http://dx.doi.org/10.1093/rheumatology/keab166 |
Ejemplares similares
-
Corrigendum to: A systematic review and meta-analysis to inform
cancer screening guidelines in idiopathic inflammatory
myopathies
por: Oldroyd, Alexander G S, et al.
Publicado: (2021) -
Recent developments in classification criteria and diagnosis guidelines for idiopathic inflammatory myopathies
por: Oldroyd, Alexander, et al.
Publicado: (2018) -
A review of accelerometer-derived physical activity in the idiopathic inflammatory myopathies
por: Oldroyd, Alexander, et al.
Publicado: (2019) -
Patient insights on living with idiopathic inflammatory myopathy and the limitations of disease activity measurement methods – a qualitative study
por: Oldroyd, Alexander, et al.
Publicado: (2020) -
The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort
por: Parker, Matthew J S, et al.
Publicado: (2019)